Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Verrica Pharmaceuticals Inc. (VRCA:NASDAQ), powered by AI.
Verrica Pharmaceuticals Inc. is currently trading at $6.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Verrica Pharmaceuticals Inc. on Alpha Lenz.
View Verrica Pharmaceuticals Inc.'s valuation metrics on Alpha Lenz.
“Verrica Pharmaceuticals Inc.'s ROE is -240.4%. Explore profitability and growth together.”
Ask for details →Verrica Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative dermatological treatments, primarily for skin conditions with high unmet medical need. The company is known for its expertise in topical therapies, with a primary emphasis on non-systemic treatments that address prevalent skin diseases such as molluscum contagiosum and common warts. Verrica Pharmaceuticals operates in the healthcare and pharmaceuticals sector, where it leverages scientific research and clinical development to create solutions that improve the standard of care for both patients and healthcare professionals. The company's activities significantly impact the dermatology field, aiming to introduce new, effective therapies for conditions often underserved in the current market. With its commitment to advancing medical treatment options in dermatology, Verrica Pharmaceuticals plays a vital role in meeting patient needs and shaping innovation within this specialized industry.
“Verrica Pharmaceuticals Inc.'s ROE is -240.4%. Explore profitability and growth together.”
Ask for details →Verrica Pharmaceuticals Inc. (ticker: VRCA) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 71 employees.
The current price is $6 with a P/E ratio of -x and P/B of -x.
ROE is -240.35% and operating margin is -33.56%. Annual revenue is $36M.